Programmed polymeric devices for pulsed drug delivery

被引:65
作者
Stubbe, BG [1 ]
De Smedt, SC [1 ]
Demeester, J [1 ]
机构
[1] State Univ Ghent, Dept Pharmaceut, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium
关键词
drug delivery; pulsatile programmed drug delivery; pulsed drug release; vaccine delivery;
D O I
10.1023/B:PHAM.0000045223.45400.01
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pharmaceutical research strives to design drug delivery systems that respond to therapeutic needs. Considering the facts that physiologic parameters ( e. g., heart rate, blood pressure, and plasma concentration of hormones, plasma proteins, and enzymes) display constancy over time, drug delivery systems with a constant release profile have been designed. However, because of circadian rhythms in physiologic parameters and pathologic conditions ( e. g., asthma, angina pectoris), the conventional paradigm concerning drug concentrations "the flatter the better" may not be what the organism may need. Instead, to correlate with our biological needs, "precisely timed drug delivery,"which could be accomplished with "programmable dosage forms," is required. Precisely timed drug delivery may maximize therapeutic efficacy, may minimize dose frequency, and may reduce toxicity by avoiding side effects and drug tolerance. This paper outlines the concepts that have been proposed to release drugs in a pulsed manner from pharmaceutical devices.
引用
收藏
页码:1732 / 1740
页数:9
相关论文
共 61 条
[1]   DETERMINANTS OF RELEASE RATE OF TETANUS VACCINE FROM POLYESTER MICROSPHERES [J].
ALONSO, MJ ;
COHEN, S ;
PARK, TG ;
GUPTA, RK ;
SIBER, GR ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :945-953
[2]  
Alza Corp, 1993, Osmotically driven delivery device with expandable orifice for pulsatile delivery effect, Patent No. [US5221278, 5221278]
[3]   Electrically enhanced transdermal delivery of a macromolecule [J].
Badkar, AV ;
Banga, AK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (07) :907-912
[4]  
BAKER RW, 1975, Patent No. 3952741
[5]  
BARCLAY B, 1988, Patent No. 4751071
[6]   Effect of sonication parameters on transdermal delivery of insulin to hairless rats [J].
Boucaud, A ;
Garrigue, MA ;
Machet, L ;
Vaillant, L ;
Patat, F .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (1-2) :113-119
[7]   In vitro testing of a pulsatile delivery system and its in vivo application for immunisation against tetanus toxoid [J].
Cardamone, M ;
Lofthouse, SA ;
Lucas, JC ;
Lee, RP ;
ODonoghue, M ;
Brandon, MR .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (03) :205-219
[8]  
CLELAND JL, 1994, AIDS RES HUM RETROV, V10, pS21
[9]   Development of a single-shot subunit vaccine for HIV-1 .3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120 [J].
Cleland, JL ;
Barron, L ;
Daugherty, A ;
Eastman, D ;
Kensil, C ;
Lim, A ;
Weissburg, RP ;
Wrin, T ;
Vennari, J ;
Powell, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1350-1357
[10]   Development of a single-shot subunit vaccine for HIV-1 .2. Defining optimal autoboost characteristics to maximize the humoral immune response [J].
Cleland, JL ;
Barron, L ;
Berman, PW ;
Daugherty, A ;
Gregory, T ;
Lim, A ;
Vennari, J ;
Wrin, T ;
Powell, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1346-1349